Nektar Therapeutics
Symbole: 0UNL.L
LSE
1.65
USDPrix du marché aujourd'hui
-1.1419
Ratio P/E
0.0069
Ratio PEG
302.98M
Cap MRK
- 0.00%
Rendement DIV
Nektar Therapeutics Structure de gestion
Informations sur la direction
Nom de l'entreprise | Titre de l'entreprise |
---|---|
Vivian Wu | Director of Investor Relations & Corporate Affairs |
Dr. Jonathan Zalevsky Ph.D. | Chief Research & Development Officer |
Ms. Jennifer Ruddock | Chief Business Officer |
Dr. Mary Tagliaferri L.Ac., M.D. | Chief Medical Officer |
Ms. Sandra A. Gardiner | Interim Chief Financial Officer |
Mr. Mark A. Wilson | Senior Vice President, Chief Legal Officer & Secretary |
Mr. Robert Bacci | Senior Vice President of Human Resources & Facilities Operations |
Mr. Howard W. Robin | Chief Executive Officer, President & Director |
Actions similaires
Vous pouvez également être intéressé par :0HL9.L
Direction générale :
- Mr. Michael Wolf
- Mr. Alexander Fu...
- Mary Beth Sandin
0J2O.L
Direction générale :
- Ms. Amy Marinne Fox
- Dr. Christopher ...
- Ms. Kristin Schw...
0T6G.L
Direction générale :
- Mr. Charles Mich...
- Ms. Theresa McNeely
- Dr. Saswati Chat...
W8A.DE
Direction générale :
- Dr. Neal Joseph S...
- Mr. Timothy C. We...
- Ms. Elizabeth L. ...
0OCQ.L
Direction générale :
- Mr. John Felitti...
- Mr. James Wentwo...
- Ms. Gaelle Stadtler
0RD1.L
Direction générale :
- Ms. Maria Lundqvist
- Mr. Fredrik Joab...
- Mr. Jon U. Garay ...
0QKQ.L
Direction générale :
- Mr. Jeremy Meine...
- Ms. Michelle Lock
- Mr. Paolo Galfetti
0HOJ.L
Direction générale :
- Jenna Cohen
- Ms. Ariel Hurley
- Mr. Alexis A. Bor...
0574.HK
Direction générale :
- Mr. Qinghai Ma
- Mr. Hongbing Yuan
- Ms. Yuen Ling La...
0JDB.L
Direction générale :
- Ms. Hoki Luk
- Dr. W. Michael Ko...
- Ms. Ana J. Schrank